These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 21119301

  • 1. [The enhanced clinical efficacy by treated years and the sustained efficacy after treatment of sublingual immunotherapy for Japanese cedar pollinosis].
    Yuta A, Ogihara H, Miyamoto Y, Takeuchi K, Okubo K.
    Arerugi; 2010 Nov; 59(11):1552-61. PubMed ID: 21119301
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
    Sakashita M, Yamada T, Imoto Y, Hirota T, Tamari M, Ito Y, Kubo S, Osawa Y, Takahashi N, Fujieda S.
    Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
    [Abstract] [Full Text] [Related]

  • 7. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A, Miyamoto Y, Ogihara H, Hattori R, Okubo K.
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H, White P, Annila I, Poole J, Andre C, Frew A.
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
    Yuta A, Ogawa Y, Suzuki Y, Ogihara H, Ohta N, Kozaki H, Shimizu T.
    Arerugi; 2017 Apr; 66(9):1172-1180. PubMed ID: 29129888
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
    Sakurai T, Yonekura S, Iinuma T, Sakurai D, Morimoto Y, Kaneko S, Okamoto Y.
    Int Arch Allergy Immunol; 2018 Apr; 177(3):245-254. PubMed ID: 30021201
    [Abstract] [Full Text] [Related]

  • 17. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP, Ricciardi L, Isola S, Savi E, Parmiani S, Puccinelli P, Musarra A.
    Allergol Immunopathol (Madr); 1996 Apr; 24(4):146-51. PubMed ID: 8939269
    [Abstract] [Full Text] [Related]

  • 18. Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis.
    Fujimura T, Yonekura S, Horiguchi S, Taniguchi Y, Saito A, Yasueda H, Inamine A, Nakayama T, Takemori T, Taniguchi M, Sakaguchi M, Okamoto Y.
    Clin Immunol; 2011 Apr; 139(1):65-74. PubMed ID: 21300571
    [Abstract] [Full Text] [Related]

  • 19. The induced regulatory T cell level, defined as the proportion of IL-10(+)Foxp3(+) cells among CD25(+)CD4(+) leukocytes, is a potential therapeutic biomarker for sublingual immunotherapy: a preliminary report.
    Fujimura T, Yonekura S, Taniguchi Y, Horiguchi S, Saito A, Yasueda H, Nakayama T, Takemori T, Taniguchi M, Sakaguchi M, Okamoto Y.
    Int Arch Allergy Immunol; 2010 Apr; 153(4):378-87. PubMed ID: 20559004
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.